Cyclerion Therapeutics Stock Price History
| CYCN Stock | USD 2.57 0.04 1.58% |
Below is the normalized historical share price chart for Cyclerion Therapeutics extending back to March 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cyclerion Therapeutics stands at 2.57, as last reported on the 11th of November 2024, with the highest price reaching 2.76 and the lowest price hitting 2.47 during the day.
If you're considering investing in Cyclerion Stock, it is important to understand the factors that can impact its price. Cyclerion Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0188, which signifies that the company had a -0.0188% return per unit of standard deviation over the last 3 months. Cyclerion Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cyclerion Therapeutics' mean deviation of 4.59, and Risk Adjusted Performance of (0) to double-check the risk estimate we provide.
At this time, Cyclerion Therapeutics' Sale Purchase Of Stock is very stable compared to the past year. As of the 11th of November 2024, Stock Based Compensation To Revenue is likely to grow to 19.89, while Total Stockholder Equity is likely to drop about 10.7 M. . At this time, Cyclerion Therapeutics' Price To Sales Ratio is very stable compared to the past year. As of the 11th of November 2024, Price Book Value Ratio is likely to grow to 0.73, while Price Earnings Ratio is likely to drop (0.39). Cyclerion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 2019 | 200 Day MA 2.9013 | 50 Day MA 2.7647 | Beta 1.924 |
Cyclerion |
Sharpe Ratio = -0.0188
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYCN |
Estimated Market Risk
| 6.04 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cyclerion Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyclerion Therapeutics by adding Cyclerion Therapeutics to a well-diversified portfolio.
Price Book 0.7247 | Enterprise Value Ebitda 0.563 | Price Sales 55.5007 | Shares Float 1.2 M | Wall Street Target Price 4 |
Cyclerion Therapeutics Stock Price History Chart
There are several ways to analyze Cyclerion Stock price data. The simplest method is using a basic Cyclerion candlestick price chart, which shows Cyclerion Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 12, 2024 | 3.16 |
| Lowest Price | October 14, 2024 | 2.4 |
Cyclerion Therapeutics November 11, 2024 Stock Price Synopsis
Various analyses of Cyclerion Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cyclerion Stock. It can be used to describe the percentage change in the price of Cyclerion Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cyclerion Stock.| Cyclerion Therapeutics Price Daily Balance Of Power | 0.14 | |
| Cyclerion Therapeutics Accumulation Distribution | 1,090 | |
| Cyclerion Therapeutics Price Rate Of Daily Change | 1.02 | |
| Cyclerion Therapeutics Price Action Indicator | (0.03) |
Cyclerion Therapeutics November 11, 2024 Stock Price Analysis
Cyclerion Stock Price History Data
The price series of Cyclerion Therapeutics for the period between Tue, Aug 13, 2024 and Mon, Nov 11, 2024 has a statistical range of 0.76 with a coefficient of variation of 7.91. The prices are distributed with arithmetic mean of 2.78. The median price for the last 90 days is 2.81. The company had 1:20 stock split on 16th of May 2023.| Open | High | Low | Close | Volume | ||
| 11/11/2024 | 2.76 | 2.76 | 2.47 | 2.57 | 10,373 | |
11/11/2024 | 2.55 | 2.78 | 2.50 | 2.53 | ||
| 11/08/2024 | 2.55 | 2.78 | 2.50 | 2.53 | 11,726 | |
| 11/07/2024 | 2.80 | 2.80 | 2.45 | 2.47 | 14,265 | |
| 11/06/2024 | 2.79 | 2.79 | 2.60 | 2.60 | 24,355 | |
| 11/05/2024 | 2.80 | 2.99 | 2.64 | 2.77 | 38,023 | |
| 11/04/2024 | 2.99 | 3.15 | 2.32 | 2.64 | 96,665 | |
| 11/01/2024 | 3.43 | 3.74 | 2.88 | 2.95 | 124,940 | |
| 10/31/2024 | 3.39 | 3.39 | 2.64 | 2.89 | 52,216 | |
| 10/30/2024 | 3.27 | 3.47 | 2.97 | 3.00 | 62,020 | |
| 10/29/2024 | 3.18 | 4.13 | 3.04 | 3.04 | 104,866 | |
| 10/28/2024 | 3.05 | 3.16 | 3.05 | 3.16 | 1,272 | |
| 10/25/2024 | 3.10 | 3.17 | 3.00 | 3.03 | 20,303 | |
| 10/24/2024 | 2.85 | 3.08 | 2.80 | 3.00 | 9,635 | |
| 10/23/2024 | 2.85 | 3.00 | 2.71 | 2.87 | 19,563 | |
| 10/22/2024 | 2.99 | 3.04 | 2.80 | 2.84 | 12,408 | |
| 10/21/2024 | 2.35 | 2.91 | 2.35 | 2.91 | 24,242 | |
| 10/18/2024 | 2.53 | 2.77 | 2.35 | 2.50 | 20,451 | |
| 10/17/2024 | 2.44 | 2.48 | 2.29 | 2.40 | 28,269 | |
| 10/16/2024 | 2.60 | 2.70 | 2.44 | 2.52 | 15,188 | |
| 10/15/2024 | 2.58 | 2.58 | 2.43 | 2.43 | 611.00 | |
| 10/14/2024 | 2.58 | 2.60 | 2.39 | 2.40 | 5,311 | |
| 10/11/2024 | 2.52 | 2.70 | 2.52 | 2.55 | 2,646 | |
| 10/10/2024 | 2.54 | 2.70 | 2.52 | 2.56 | 8,344 | |
| 10/09/2024 | 2.65 | 2.65 | 2.59 | 2.60 | 1,257 | |
| 10/08/2024 | 2.62 | 2.93 | 2.60 | 2.65 | 14,662 | |
| 10/07/2024 | 2.40 | 2.79 | 2.35 | 2.50 | 21,297 | |
| 10/04/2024 | 2.63 | 2.63 | 2.43 | 2.43 | 1,423 | |
| 10/03/2024 | 2.70 | 2.70 | 2.51 | 2.51 | 1,547 | |
| 10/02/2024 | 2.55 | 2.73 | 2.50 | 2.51 | 7,443 | |
| 10/01/2024 | 2.52 | 2.52 | 2.52 | 2.52 | 150.00 | |
| 09/30/2024 | 2.73 | 2.85 | 2.50 | 2.59 | 9,617 | |
| 09/27/2024 | 2.65 | 2.75 | 2.51 | 2.62 | 10,104 | |
| 09/26/2024 | 2.70 | 2.85 | 2.50 | 2.70 | 16,942 | |
| 09/25/2024 | 2.74 | 2.90 | 2.74 | 2.75 | 6,241 | |
| 09/24/2024 | 2.74 | 2.88 | 2.74 | 2.87 | 2,076 | |
| 09/23/2024 | 2.92 | 2.94 | 2.75 | 2.75 | 7,888 | |
| 09/20/2024 | 2.91 | 2.95 | 2.81 | 2.93 | 3,409 | |
| 09/19/2024 | 2.81 | 2.83 | 2.81 | 2.83 | 2,172 | |
| 09/18/2024 | 2.93 | 2.93 | 2.81 | 2.81 | 3,495 | |
| 09/17/2024 | 3.00 | 3.03 | 2.85 | 2.93 | 2,720 | |
| 09/16/2024 | 2.80 | 3.00 | 2.80 | 3.00 | 1,543 | |
| 09/13/2024 | 2.92 | 3.00 | 2.88 | 2.90 | 900.00 | |
| 09/12/2024 | 2.93 | 3.16 | 2.90 | 3.16 | 1,323 | |
| 09/11/2024 | 2.76 | 3.11 | 2.76 | 3.01 | 6,451 | |
| 09/10/2024 | 2.86 | 2.86 | 2.75 | 2.75 | 2,378 | |
| 09/09/2024 | 2.90 | 3.10 | 2.90 | 3.10 | 3,925 | |
| 09/06/2024 | 2.93 | 2.93 | 2.93 | 2.93 | 417.00 | |
| 09/05/2024 | 3.15 | 3.15 | 2.96 | 3.05 | 818.00 | |
| 09/04/2024 | 2.75 | 2.99 | 2.75 | 2.99 | 531.00 | |
| 09/03/2024 | 2.77 | 3.00 | 2.71 | 2.88 | 2,538 | |
| 08/30/2024 | 2.93 | 2.93 | 2.93 | 2.93 | 292.00 | |
| 08/29/2024 | 2.80 | 3.15 | 2.76 | 3.15 | 1,388 | |
| 08/28/2024 | 2.98 | 3.25 | 2.57 | 2.57 | 8,621 | |
| 08/27/2024 | 2.83 | 2.83 | 2.49 | 2.75 | 8,677 | |
| 08/26/2024 | 2.96 | 2.96 | 2.88 | 2.88 | 1,327 | |
| 08/23/2024 | 3.00 | 3.00 | 2.76 | 2.93 | 705.00 | |
| 08/22/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 35.00 | |
| 08/21/2024 | 2.80 | 2.80 | 2.57 | 2.60 | 3,883 | |
| 08/20/2024 | 2.94 | 2.95 | 2.62 | 2.78 | 3,299 | |
| 08/19/2024 | 2.77 | 3.04 | 2.53 | 2.60 | 2,200 |
About Cyclerion Therapeutics Stock history
Cyclerion Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cyclerion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cyclerion Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cyclerion Therapeutics stock prices may prove useful in developing a viable investing in Cyclerion Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.3 M | 1.9 M | |
| Net Loss | -50.7 M | -53.2 M |
Cyclerion Therapeutics Quarterly Net Working Capital |
|
Cyclerion Therapeutics Stock Technical Analysis
Cyclerion Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Cyclerion Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cyclerion Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cyclerion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cyclerion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclerion Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cyclerion Stock, please use our How to Invest in Cyclerion Therapeutics guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclerion Therapeutics. If investors know Cyclerion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclerion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.29) | Revenue Per Share 0.586 | Quarterly Revenue Growth 0.141 | Return On Assets (0.47) | Return On Equity (1.50) |
The market value of Cyclerion Therapeutics is measured differently than its book value, which is the value of Cyclerion that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclerion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cyclerion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclerion Therapeutics' market value can be influenced by many factors that don't directly affect Cyclerion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclerion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclerion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclerion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.